Evidence map›Paper›PMID 41951661›Full record

ArticleNature communications2026

Activation mechanism and integrated one-pot assay of chiral-like cRNA-enhanced CRISPR/Cas12a systems.

Yonghui Li, Niu Feng, Xueyang Wu, Beiwei Zhu, Yiping Chen

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yonghui Li *State Key Laboratory of Marine Food Processing and Safety Control, Dalian Polytechnic University, Dalian, China.
Niu Feng *College of Food Science and Technology, Huazhong Agricultural University, Wuhan, China.
Xueyang WuState Key Laboratory of Marine Food Processing and Safety Control, Dalian Polytechnic University, Dalian, China.
Beiwei ZhuState Key Laboratory of Marine Food Processing and Safety Control, Dalian Polytechnic University, Dalian, China.
Yiping ChenState Key Laboratory of Marine Food Processing and Safety Control, Dalian Polytechnic University, Dalian, China. chenyiping@mail.hzau.edu.cn.ORCID http://orcid.org/0000-0001-9309-2730

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 5'-repeat fragments released during pre-crRNA maturation are critical yet understudied components of the CRISPR/Cas12a system. Here, we demonstrate that engineered 5'-repeat fragments can potently activate Cas12a cleavage, with efficiency strongly dependent on the length of the 3'-spacer. Strikingly, complete truncation of the 3'-spacer generates a "chiral-like crRNA" conformation that induces a delayed-switch mode of Cas12a activation, fundamentally distinct from conventional mature crRNA. Leveraging this characteristic, we develop the delayed cleavage feature-mediated one-pot sensing strategy that resolves the long-standing challenge of incompatibility between Cas12a-based cleavage reaction and nucleic acid amplification, achieving a 1000-fold improvement in sensitivity over that of the conventional mature crRNA-mediated one-pot method. Furthermore, we integrate a cleavage-based one-pot assay with a portable temperature-controlled fluorescence imaging device to create an on-site diagnostic platform for high-throughput screening. Our study further advances the understanding of the crRNA-guided mechanism and facilitates the expansion of its applications in genome editing and molecular diagnostics.

Indexed as

Bacterial ProteinsCRISPR-Associated ProteinsCRISPR-Cas SystemsEndodeoxyribonucleasesGene EditingNucleic Acid Amplification TechniquesNucleic Acid ConformationBacterial ProteinsCas12a proteinCRISPR-Associated ProteinsEndodeoxyribonucleases

Identifiers

PMID41951661
PMCPMC13237004

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.